The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

It is not yet clear when that national security investigation will end, and if and how tariffs on pharmaceuticals will be ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque.

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

The issue is nothing new, but it has been receiving more attention as the Trump administration, lawmakers and community ...

his company would be transparent with consumers about the cost of tariffs and broker fees and pass them "directly" on to customers. There would be no way for Cost Plus Drugs to "eat" the costs.

Kessler, a former commissioner of the Food and Drug Administration, is the author of the forthcoming book “Diet, Drugs, and Dopamine ... and a half years was of no help to me.